TPP-resveratrol
TPP-resveratrol is a conjugate of Resveratrol (HY-16561) and triphenylphosphine (TPP) with anticancer activity. TPP-resveratrol increases the potency of Resveratrol through mitochondrial-targeted delivery and induces mitochondria-mediated apoptosis[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tpp-resveratrol.html
Purity
99.76
Solubility
DMSO : 116.67 mg/mL (ultrasonic)
Smiles
O=C(CCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)OC4=CC(O)=CC(/C=C/C5=CC=C(C=C5)O)=C4.[Br-]
Molecular Formula
C36H32BrO4P
Molecular Weight
639.51
References & Citations
[1]Jiang L, et al. The anti-cancer effects of mitochondrial-targeted triphenylphosphonium–resveratrol conjugate on breast cancer cells[J]. Pharmaceuticals, 2022, 15 (10) : 1271.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL307227V 500 µL Each
PBLD Human shRNA Lentiviral Particle (Locus ID 64081)
Sign In for Pricing
View Details 1402-9708 10 / Box
TempPlate semi-skirted polypropylene 0.2 mL 96-well PCR plate, contoured sides, standard depth, assorted. Two/sleeve, 10/box.
Sign In for Pricing
View Details